A stampede of recent clinical studies suggests that we are on the cusp of developing well-tolerated, orally delivered drugs that can effectively eradicate hepatitis C virus from most, if not all, infected individuals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

References
Prince, A. M. et al. Lancet 2, 241–246 (1974).
Alter, H. J. et al. Lancet 2, 838–841 (1975).
Choo, Q. L. et al. Science 244, 359–362 (1989).
Mohd Hanafiah, K., Groeger, J., Flaxman, A. D. & Wiersma, S. T. Hepatology 57, 1333–1342 (2013).
Feld, J. J. et al. N. Engl. J. Med. 370, 1594–1603 (2014).
Afdhal, N. et al. N. Engl. J. Med. 370, 1889–1898 (2014).
Afdhal, N. et al. N. Engl. J. Med. 370, 1483–1493 (2014).
Kowdley, K. V. et al. N. Engl. J. Med. 370, 222–232 (2014).
Kowdley, K. V. et al. N. Engl. J. Med. 370, 1879–1888 (2014).
Zeuzem, S. et al. N. Engl. J. Med. 370, 1604–1614 (2014).
Sulkowski, M. S., Jacobson, I. M. & Nelson, D. R. N. Engl. J. Med. 370, 1560–1561 (2014).
Heim, M. H. Nature Rev. Immunol. 13, 535–542 (2013).
Lawitz, E. et al. N. Engl. J. Med. 368, 1878–1887 (2013).
Denniston, M. M., Klevens, R. M., McQuillan, G. M. & Jiles, R. B. Hepatology 55, 1652–1661 (2012).
Dore, G. J., Ward, J. & Thursz, M. J. Viral Hepat. 21 (suppl. 1) 1–4 (2014).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rice, C., Saeed, M. Treatment triumphs. Nature 510, 43–44 (2014). https://doi.org/10.1038/510043a
Published:
Issue Date:
DOI: https://doi.org/10.1038/510043a